Prognostic performance of endothelial biomarkers to early predict clinical deterioration of patients with suspected bacterial infection and sepsis admitted to the emergency department
Thomas Lafon(Inserm), Sophie Blein(Université Claude Bernard Lyon 1), Alexandre Pachot(bioMérieux (France)), Karim Tazarourte(Université Claude Bernard Lyon 1), Christine Vallejo(Inserm), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Sai͏̈d Laribi(Université de Tours), Marie-Angélique Cazalis(Université Claude Bernard Lyon 1), Bruno François(Inserm)
Cited by 17
Related Papers
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
The SOFA score—development, utility and challenges of accurate assessment in clinical trials
|Critical Care|2019|976
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
|New England Journal of Medicine|2005|890